Retrospective study of perampanel efficacy and tolerability in myoclonic seizures-Reference-Cited by-同舟云学术

Retrospective study of perampanel efficacy and tolerability in myoclonic seizures

Published:2018-03-24 Issue:2 Volume:138 Page:122-129
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Gil-López F. J.¹^ORCID,Montoya J.²,Falip M.³^ORCID,Aparicio J.⁴,López-González F. J.⁵,Toledano R.⁶,Gil-Nagel A.⁶,Molins A.⁷,García I.⁸,Serrano P.⁹,Domenech G.¹⁰,Torres F.¹⁰,Donaire A.¹¹¹^ORCID,Carreño M.¹¹¹

Affiliation:

1. Epilepsy Unit; Department of Neurology; Hospital Clínic de Barcelona; Barcelona Spain

2. Department of Neurology; Hospital Lluis Alcanyís; Xàtiva Spain

3. Epilepsy Unit; Department of Neurology; Hospital Universitari de Bellvitge; Hospitalet de Llobregat; Barcelona Spain

4. Epilepsy Unit; Department of Neurology; Hospital Sant Joan de Déu; Barcelona Spain

5. Epilepsy Unit; Department of Neurology; Complexo Hospitalario Universitario de Santiago de Compostela; A Coruña Spain

6. Epilepsy Unit; Department of Neurology; Hospital Ruber Internacional; Madrid Spain

7. Department of Neurology; Hospital Josep Trueta de Girona; Girona Spain

8. Epilepsy Unit; Hospital Clínico Universitario San Carlos; Madrid Spain

9. Department of Neurology; Hospital Carlos Haya; Málaga Spain

10. Medical Statistics Core Facility; IDIBAPS-Hospital Clínic; Barcelona Spain

11. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona Spain

Funder

Eisai Europe Ltd

Investigator Initiated Study

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12931/fullpdf

Reference20 articles.

1. Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy;Hanada;Epilepsia,2011

2. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012

3. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307;Krauss;Epilepsia,2013

4. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures;Krauss;Neurology,2012

5. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies;Steinhoff;Epilepsia,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease;Current Issues in Molecular Biology;2024-07-26

2. Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-03-28

3. Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy;Journal of Clinical Medicine;2022-08-05

4. Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study;Seizure;2022-08

5. A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus;Epileptic Disorders;2022-08-01